| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |